| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 2800-2805, Copyright © 1995 by Endocrine Society
ARTICLES |
G Howard, T Nguyen, N Morrison, T Watanabe, P Sambrook, J Eisman and PJ Kelly
Bone and Mineral Research Division, Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, New South Wales, Australia.
Common vitamin D receptor (VDR) gene alleles have recently been shown to contribute to the genetic variability in bone mass and bone turnover, however, the physiological mechanisms involved are unknown. To examine this, the response to 7 days of 2 micrograms oral 1,25- dihydroxyvitamin D[1,25-(OH)2D] (calcitriol) stimulation was assessed in 21 premenopausal women, homozygous for one or other of the common VDR alleles (bb, n = 11; BB, n = 10). Indices of bone turnover and calcium homeostasis were measured during 2 weeks. Baseline osteocalcin, 1,25-(OH)2D, type I collagen carboxyterminal telopeptide, and inorganic phosphate levels were significantly higher and spinal bone mineral density was significantly lower in the BB allelic group. After calcitriol administration, similar levels of 1,25-(OH)2D were attained throughout the study in both genotypic groups. The increase in serum osteocalcin levels in the BB group was significantly less than that in the bb group (11% vs. 32%, P = 0.01). The genotype-related baseline difference in osteocalcin levels was not apparent at the similar serum 1,25-(OH)2D levels. By contrast, the baseline differences in phosphate and type I collagen carboxyterminal telopeptide persisted throughout the study. Serum ionized calcium levels did not differ between genotypes, nor did it move out of normal range values. However, parathyroid hormone was less suppressed in the low bone density group (38% vs. 11%, P = 0.01). These data indicate that the VDR alleles are associated with differences in the vitamin D endocrine system and may have important implications in relation to the pathophysiology of osteoporosis.
This article has been cited by other articles:
![]() |
P. Garnero, F. Munoz, O. Borel, E. Sornay-Rendu, and P. D. Delmas Vitamin D Receptor Gene Polymorphisms Are Associated with the Risk of Fractures in Postmenopausal Women, Independently of Bone Mineral Density J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4829 - 4835. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Colin, A. G. Uitterlinden, J. B. J. Meurs, A. P. Bergink, M. Van De Klift, Y. Fang, P. P. Arp, A. Hofman, J. P. T. M. van Leeuwen, and H. A. P. Pols Interaction between Vitamin D Receptor Genotype and Estrogen Receptor {alpha} Genotype Influences Vertebral Fracture Risk J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3777 - 3784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Palomba, F. G. Numis, G. Mossetti, D. Rendina, P. Vuotto, T. Russo, F. Zullo, C. Nappi, and V. Nunziata Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes Hum. Reprod., January 1, 2003; 18(1): 192 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Eisman Pharmacogenetics of the Vitamin D Receptor and Osteoporosis Drug Metab. Dispos., April 1, 2001; 29(4): 505 - 512. [Abstract] [Full Text] |
||||
![]() |
Y. Ban, M. Taniyama, and Y. Ban Vitamin D Receptor Gene Polymorphism Is Associated with Graves' Disease in the Japanese Population J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4639 - 4643. [Abstract] [Full Text] |
||||
![]() |
J. A. Eisman Genetics of Osteoporosis Endocr. Rev., December 1, 1999; 20(6): 788 - 804. [Abstract] [Full Text] |
||||
![]() |
T. Carling, J. Rastad, G. Åkerström, and G. Westin Vitamin D Receptor (VDR) and Parathyroid Hormone Messenger Ribonucleic Acid Levels Correspond to Polymorphic VDR Alleles in Human Parathyroid Tumors J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2255 - 2259. [Abstract] [Full Text] |
||||
![]() |
G. Howard, T. Nguyen, and N. Morrison Genetic Influences on Bone Density: Physiological Correlates of Vitamin D Receptor Gene Alleles in Premenopausal Women. Notification of Genotype Corrections J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 1043 - 1043. [Full Text] |
||||
![]() |
J. Sainz, J. M. Van Tornout, M. L. Loro, J. Sayre, T. F. Roe, and V. Gilsanz Vitamin D-Receptor Gene Polymorphisms and Bone Density in Prepubertal American Girls of Mexican Descent N. Engl. J. Med., July 10, 1997; 337(2): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Carling, P. Ridefelt, P. Hellman, J. Rastad, and G. Akerstrom Vitamin D Receptor Polymorphisms Correlate to Parathyroid Cell Function in Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1772 - 1775. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |